80 results on '"Lippmann N"'
Search Results
2. Painful ulcers in a young male refugee
- Author
-
Jochims, F., primary, Lippmann, N., additional, and Simon, J. C., additional
- Published
- 2024
- Full Text
- View/download PDF
3. Use Case HELP ‒ Nutzung der Datenintegrationszentren für eine Evaluationsstudie und vorläufige Ergebnisse
- Author
-
Scherag, A, Alaid, S, Ammon, D, Brandes, J, Dürschmid, A, Fortmann, J, Friebel, K, Hagel, S, He, D, Hetfeld, P, Geihs, S, Ihle, R, Kahle, S, Koi, V, Konik, M, Kretzschmann, F, Kruse, H, Lippmann, N, Lübbert, C, Marx, G, Mikolajczyk, R, Moritz, S, Müller, C, Müller, S, Palm, J, Pérez Garriga, A, Pethukova, J, Pietzner, D, Popp, M, Rebenstorff, M, Renz, J, Rißner, F, Röhrig, R, Saleh, K, Schlöcker, A, Schönherr, S, Spreckelsen, C, Stahlmann, J, Stolz, A, Thon, S, Thomas, E, Tiller, D, Wendt, S, Wendt, T, Winnekens, P, Witzke, O, Pletz, M, Scherag, A, Alaid, S, Ammon, D, Brandes, J, Dürschmid, A, Fortmann, J, Friebel, K, Hagel, S, He, D, Hetfeld, P, Geihs, S, Ihle, R, Kahle, S, Koi, V, Konik, M, Kretzschmann, F, Kruse, H, Lippmann, N, Lübbert, C, Marx, G, Mikolajczyk, R, Moritz, S, Müller, C, Müller, S, Palm, J, Pérez Garriga, A, Pethukova, J, Pietzner, D, Popp, M, Rebenstorff, M, Renz, J, Rißner, F, Röhrig, R, Saleh, K, Schlöcker, A, Schönherr, S, Spreckelsen, C, Stahlmann, J, Stolz, A, Thon, S, Thomas, E, Tiller, D, Wendt, S, Wendt, T, Winnekens, P, Witzke, O, and Pletz, M
- Published
- 2023
4. Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data
- Author
-
Bielicki, Julia A., Sharland, Mike, Johnson, Alan P., Henderson, Katherine L., Cromwell, David A., Berger, C., Esposito, S., Danieli, E., Tenconi, R., Folgori, L., Bernaschi, P., Santiago, B., Saavedra, J., Cercenado, E., Brett, A., Rodrigues, F., Cizman, M., Jazbec, J., Babnik, J., Pavčnik, Maja, Pirš, M., Premrov, M. Mueller, Lindner, M., Borte, M., Lippmann, N., Schuster, V., Thürmer, A., Lander, F., Elias, J., Liese, J., Durst, A., Weichert, S., Schneider, C., Hufnagel, M., Rack, A., Hübner, J., Dubos, F., Lagree, M., Dessein, R., Tissieres, P., Cuzon, G., Gajdos, V., Doucet-Populaire, F., Usonis, V., Gurksniene, V., Bernatoniene, G., Tsolia, M., Spyridis, N., Lebessi, E., Doudoulakakis, A., Kyriakou, A., Lutsar, I., Kõljalg, S., Schülin, T., and Warris, A.
- Published
- 2016
- Full Text
- View/download PDF
5. Context-aware genomic surveillance reveals hidden transmission of a carbapenemase-producing Klebsiella pneumoniae.
- Author
-
Viehweger, A, Blumenscheit, C, Lippmann, N, Wyres, KL, Brandt, C, Hans, JB, Hölzer, M, Irber, L, Gatermann, S, Lübbert, C, Pletz, MW, Holt, KE, König, B, Viehweger, A, Blumenscheit, C, Lippmann, N, Wyres, KL, Brandt, C, Hans, JB, Hölzer, M, Irber, L, Gatermann, S, Lübbert, C, Pletz, MW, Holt, KE, and König, B
- Abstract
Genomic surveillance can inform effective public health responses to pathogen outbreaks. However, integration of non-local data is rarely done. We investigate two large hospital outbreaks of a carbapenemase-carrying Klebsiella pneumoniae strain in Germany and show the value of contextual data. By screening about 10 000 genomes, over 400 000 metagenomes and two culture collections using in silico and in vitro methods, we identify a total of 415 closely related genomes reported in 28 studies. We identify the relationship between the two outbreaks through time-dated phylogeny, including their respective origin. One of the outbreaks presents extensive hidden transmission, with descendant isolates only identified in other studies. We then leverage the genome collection from this meta-analysis to identify genes under positive selection. We thereby identify an inner membrane transporter (ynjC) with a putative role in colistin resistance. Contextual data from other sources can thus enhance local genomic surveillance at multiple levels and should be integrated by default when available.
- Published
- 2021
6. Computational modeling of crack propagation in real microstructures of steels and virtual testing of artificially designed materials
- Author
-
Mishnaevsky, Jr., L., Lippmann, N., and Schmauder, S.
- Published
- 2003
- Full Text
- View/download PDF
7. Fatales Outcome bei Pilzinfektionen mit Candida spp. nach Imlantation von Hüft- und Knieendoprothesen
- Author
-
Baur, D, Höch, A, Lippmann, N, Fakler, J, Roth, A, Josten, C, Baur, D, Höch, A, Lippmann, N, Fakler, J, Roth, A, and Josten, C
- Published
- 2019
8. Häufigkeit und klinische Präsentation von alveolärer und zystischer Echinokokkose an einem tertiären Zentrum in Deutschland: Lehren aus einer Niedrigprävalenzregion
- Author
-
Reinhardt, F, additional, Blank, V, additional, Lippmann, N, additional, Seehofer, D, additional, Lübbert, C, additional, and Karlas, T, additional
- Published
- 2019
- Full Text
- View/download PDF
9. Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data
- Author
-
Bielicki, J. A., Sharland, M., Johnson, A. P., Henderson, K. L., Cromwell, D. A., Berger, C., Esposito, Susanna Maria Roberta, Danieli, E., Tenconi, R., Folgori, L., Bernaschi, P., Santiago, B., Saavedra, J., Cercenado, E., Brett, A., Rodrigues, F., Cizman, M., Jazbec, J., Babnik, J., Pavčnik, M., Pirš, M., Mueller Premrov, M., Lindner, M., Borte, M., Lippmann, N., Schuster, V., Thürmer, A., Lander, F., Elias, J., Liese, J., Durst, A., Weichert, S., Schneider, C., Hufnagel, M., Rack, A., Hübner, J., Dubos, F., Lagree, M., Dessein, R., Tissieres, P., Cuzon, G., Gajdos, V., Doucet Populaire, F., Usonis, V., Gurksniene, V., Bernatoniene, G., Tsolia, M., Spyridis, N., Lebessi, E., Doudoulakakis, A., Lutsar, I., Kõljalg, S., Schülin, T., and Warris, A.
- Subjects
Male ,0301 basic medicine ,Microbiology (medical) ,medicine.medical_specialty ,Adolescent ,030106 microbiology ,MEDLINE ,Bacteremia ,Microbial Sensitivity Tests ,Drug resistance ,Decision Support Techniques ,03 medical and health sciences ,Bayes' theorem ,pharmacology ,pharmacology (medical) ,infectious diseases ,0302 clinical medicine ,Antibiotic resistance ,030225 pediatrics ,Humans ,Medicine ,Pharmacology (medical) ,Medical prescription ,Child ,Intensive care medicine ,Pharmacology ,Bacteria ,business.industry ,Incidence ,Incidence (epidemiology) ,Infant, Newborn ,Infant ,Bayes Theorem ,medicine.disease ,Anti-Bacterial Agents ,Regimen ,Infectious Diseases ,Child, Preschool ,Epidemiological Monitoring ,Emergency medicine ,Female ,business - Abstract
OBJECTIVES: The objective of this study was to evaluate the ability of weighted-incidence syndromic combination antibiograms (WISCAs) to inform the selection of empirical antibiotic regimens for suspected paediatric bloodstream infections (BSIs) by comparing WISCAs derived using data from single hospitals and from a multicentre surveillance dataset. METHODS: WISCAs were developed by estimating the coverage of five empirical antibiotic regimens for childhood BSI using a Bayesian decision tree. The study used microbiological data on ∼2000 bloodstream isolates collected over 2 years from 19 European hospitals. We evaluated the ability of a WISCA to show differences in regimen coverage at two exemplar hospitals. For each, a WISCA was first calculated using only their local data; a second WISCA was calculated using pooled data from all 19 hospitals. RESULTS: The estimated coverage of the five regimens was 72%-86% for Hospital 1 and 79%-94% for Hospital 2, based on their own data. In both cases, the best regimens could not be definitively identified because the differences in coverage were not statistically significant. For Hospital 1, coverage estimates derived using pooled data gave sufficient precision to reveal clinically important differences among regimens, including high coverage provided by a narrow-spectrum antibiotic combination. For Hospital 2, the hospital and pooled data showed signs of heterogeneity and the use of pooled data was judged not to be appropriate. CONCLUSIONS: The Bayesian WISCA provides a useful approach to pooling information from different sources to guide empirical therapy and could increase confidence in the selection of narrow-spectrum regimens.
- Published
- 2015
- Full Text
- View/download PDF
10. In-situ observation of damage evolution and fracture in AlSi7Mg0.3 cast alloys
- Author
-
Mishnaevsky, L.L, Jr, Lippmann, N, Schmauder, S, and Gumbsch, P
- Published
- 1999
- Full Text
- View/download PDF
11. Einfluss des Alters auf das Erregerspektrum bei Frühinfekten
- Author
-
Behrendt, D, Eisner, R, Lippmann, N, Rodloff, A, Josten, C, Behrendt, D, Eisner, R, Lippmann, N, Rodloff, A, and Josten, C
- Published
- 2017
12. Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: Application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data
- Author
-
Bielicki, J.A. Sharland, M. Johnson, A.P. Henderson, K.L. Cromwell, D.A. Berger, C. Esposito, S. Danieli, E. Tenconi, R. Folgori, L. Bernaschi, P. Santiago, B. Saavedra, J. Cercenado, E. Brett, A. Rodrigues, F. Cizman, M. Jazbec, J. Babnik, J. Pavčnik, M. Pirš, M. Mueller Premrov, M. Lindner, M. Borte, M. Lippmann, N. Schuster, V. Thürmer, A. Lander, F. Elias, J. Liese, J. Durst, A. Weichert, S. Schneider, C. Hufnagel, M. Rack, A. Hübner, J. Dubos, F. Lagree, M. Dessein, R. Tissieres, P. Cuzon, G. Gajdos, V. Doucet-Populaire, F. Usonis, V. Gurksniene, V. Bernatoniene, G. Tsolia, M. Spyridis, N. Lebessi, E. Doudoulakakis, A. Lutsar, I. Kõljalg, S. Schülin, T. Warris, A. Antibiotic Resistance Prescribing in European Children project
- Abstract
Objectives: The objective of this study was to evaluate the ability of weighted-incidence syndromic combination antibiograms (WISCAs) to inform the selection of empirical antibiotic regimens for suspected paediatric bloodstream infections (BSIs) by comparing WISCAs derived using data from single hospitals and from a multicentre surveillance dataset. Methods: WISCAs were developed by estimating the coverage of five empirical antibiotic regimens for childhood BSI using a Bayesian decision tree. The study used microbiological data on ~2000 bloodstream isolates collected over 2 years from 19 European hospitals. We evaluated the ability of a WISCA to show differences in regimen coverage at two exemplar hospitals. For each, a WISCA was first calculated using only their local data; a second WISCA was calculated using pooled data from all 19 hospitals. Results: The estimated coverage of the five regimens was 72%-86% for Hospital 1 and 79%-94% for Hospital 2, based on their own data. In both cases, the best regimens could not be definitively identified because the differences in coverage were not statistically significant. For Hospital 1, coverage estimates derived using pooled data gave sufficient precision to reveal clinically important differences among regimens, including high coverage provided by a narrow-spectrum antibiotic combination. For Hospital 2, the hospital and pooled data showed signs of heterogeneity and the use of pooled data was judged not to be appropriate. Conclusions: The Bayesian WISCA provides a useful approach to pooling information from different sources to guide empirical therapy and could increase confidence in the selection of narrow-spectrum regimens. © The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.
- Published
- 2016
13. Antibiotic resistance prevalence in routine bloodstream isolates from children's hospitals varies substantially from adult surveillance data in Europe
- Author
-
Bielicki, Ja, Lundin, R, Sharland, M, Arpec, Project, Berger, C, Esposito, S, Danieli, E, Tenconi, R, Folgori, L, Bernaschi, P, Santiago, B, Saavedra, J, Cercenado, E, Brett, A, Rodrigues, F, Cizman, M, Jazbec, J, Babnik, J, Pavcnik, M, Pirš, M, Premrov, M, Lindner, M, Borte, M, Lippmann, N, Schuster, V, Thürmer, A, Lander, F, Elias, J, Liese, J, Durst, A, Weichert, S, Schneider, C, Hufnagel, M, Rack, A, Hübner, J, Dubos, F, Lagree, M, Dessein, R, Tissieres, P, Cuzon, G, Gajdos, V, Doucet-Populaire, F, Usonis, V, Gurksniene, V, Bernatoniene, G, Tsolia, M, Spyridis, N, Lebessi, E, Doudoulakakis, A, Lutsar, I, Kõljalg, S, Schülin, T, and Warris, A
- Subjects
Microbiology (medical) ,Male ,medicine.medical_specialty ,Surveillance data ,Adolescent ,Klebsiella pneumoniae ,lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4] ,Bacteremia ,age differences ,medicine.disease_cause ,Gram-Positive Bacteria ,Enterococcus faecalis ,Microbiology ,Antibiotic resistance ,Internal medicine ,Streptococcus pneumoniae ,Drug Resistance, Bacterial ,Gram-Negative Bacteria ,medicine ,Prevalence ,Humans ,antimicrobial resistance ,Child ,routine data ,surveillance ,biology ,Pseudomonas aeruginosa ,business.industry ,Age Factors ,Infant, Newborn ,Infant ,biology.organism_classification ,Hospitals, Pediatric ,Anti-Bacterial Agents ,Europe ,Infectious Diseases ,Staphylococcus aureus ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Epidemiological Monitoring ,Female ,business ,Enterococcus faecium - Abstract
Item does not contain fulltext BACKGROUND: Surveillance of antimicrobial resistance (AMR) is central for defining appropriate strategies to deal with changing AMR levels. It is unclear whether childhood AMR patterns differ from those detected in isolates from adult patients. METHODS: Resistance percentages of nonduplicate Staphylococcus aureus, Streptococcus pneumoniae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa bloodstream isolates from children less than 18 years of age reported to the Antibiotic Resistance and Prescribing in European Children (ARPEC) project were compared with all-age resistance percentages reported by the European Antimicrobial Resistance Surveillance Network (EARS-Net) for the same pathogen-antibiotic class combinations, period and countries. In addition, resistance percentages were compared between ARPEC isolates from children less than 1 year of age and children greater than or equal to1 year of age. RESULTS: Resistance percentages for many important pathogen-antibiotic class combinations were different for ARPEC isolates compared with EARS-Net. E. coli and K. pneumoniae fluoroquinolone resistance percentages were substantially lower in ARPEC (13.4% and 17.9%) than in EARS-Net (23.0% and 30.7%), whereas the reverse was true for all pathogen-antibiotic class combinations in P. aeruginosa (for example, 27.3% aminoglycoside resistance in ARPEC, 19.3% in EARS-Net, 32.8% carbapenem resistance in ARPEC and 20.5% in EARS-Net), and for S. pneumoniae and macrolide resistance. For many Gram-negative pathogen-antibiotic class combinations, isolates from children greater than or equal to 1 year of age showed higher resistance percentages than isolates from children less than 1 year of age. CONCLUSIONS: Age-stratified presentation of resistance percentage estimates by surveillance programs will allow identification of important variations in resistance patterns between different patient groups for targeted intervention. 01 juli 2015
- Published
- 2015
14. Einfluss der Frakturregion auf das Erregerspektrum bei Frühinfekten
- Author
-
Behrendt, D, Eisner, R, Lippmann, N, Rodloff, A, Josten, C, Behrendt, D, Eisner, R, Lippmann, N, Rodloff, A, and Josten, C
- Published
- 2016
15. Verändert Diabetes mellitus das Erregerspektrum und die Erregerresistenz bei Frühinfektionen?
- Author
-
Behrendt, D, Eisner, R, Lippmann, N, Gresens, M, Rodloff, A, Josten, C, Behrendt, D, Eisner, R, Lippmann, N, Gresens, M, Rodloff, A, and Josten, C
- Published
- 2014
16. PO-0559 Candida Bloodstream Infections In A Nicu (2001–2012)
- Author
-
Pulzer, F, primary, Lippmann, N, additional, Gebauer, C, additional, Bläser, A, additional, Knüpfer, M, additional, and Thome, U, additional
- Published
- 2014
- Full Text
- View/download PDF
17. Erratum: Clostridium-difficile-Infektionen (CDI) im Wandel der Zeit – ein Thema nur für den Internisten?
- Author
-
Weis, S., additional, John, E., additional, Lippmann, N., additional, Mössner, J., additional, and Lübbert, C., additional
- Published
- 2014
- Full Text
- View/download PDF
18. Clostridium-difficile-Infektionen (CDI) im Wandel der Zeit – ein Thema nur für den Internisten?
- Author
-
Weis, S., additional, John, E., additional, Lippmann, N., additional, Mössner, J., additional, and Lübbert, C., additional
- Published
- 2013
- Full Text
- View/download PDF
19. Sensorkontrolliertes Gasoxinitrieren von Warmarbeitsstählen mit Ammoniak-Wasser-Gemischen
- Author
-
Lippmann, N., primary, Kizil, Ü., additional, and Öklü, B., additional
- Published
- 2011
- Full Text
- View/download PDF
20. Clostridium-difficile-Infektionen (CDI) imWandel der Zeit -- ein Thema nur für den Internisten?
- Author
-
Lippmann, N., John, E., Weis, S., Mössner, J., and Lübbert, C.
- Published
- 2014
- Full Text
- View/download PDF
21. 3D-finite-element-modelling of microstructures with the method of multiphase elements
- Author
-
Lippmann, N., primary, Steinkopff, Th., additional, Schmauder, S., additional, and Gumbsch, P., additional
- Published
- 1997
- Full Text
- View/download PDF
22. Modelling the fracture behaviour of high speed steels using finite element method
- Author
-
Lippmann, N., primary, Lehmann, A., additional, Steinkopff, Th., additional, and Spies, H.-J., additional
- Published
- 1996
- Full Text
- View/download PDF
23. Numerical and Experimental Study of Early Stages of the Failure of AlSi-Cast Alloys
- Author
-
Lippmann, N., primary, Schmauder, S., additional, and Gumbsch, P., additional
- Published
- 1996
- Full Text
- View/download PDF
24. Clinical management, pathogen spectrum and outcomes in patients with pyogenic liver abscess in a German tertiary-care hospital.
- Author
-
Wendt S, Bačák M, Petroff D, Lippmann N, Blank V, Seehofer D, Zimmermann L, Lübbert C, and Karlas T
- Subjects
- Humans, Male, Middle Aged, Female, Aged, Retrospective Studies, Germany epidemiology, Treatment Outcome, Adult, Aged, 80 and over, Liver Abscess, Pyogenic microbiology, Liver Abscess, Pyogenic therapy, Liver Abscess, Pyogenic diagnosis, Tertiary Care Centers, Anti-Bacterial Agents therapeutic use
- Abstract
Pyogenic liver abscesses (PLA) are life-threatening disorders and require immediate treatment, but structured evidence is sparse and treatment guidelines are not established. In a retrospective observational study of 221 adult PLA patients (mean age 63 years, 63% men) treated between 2013 and 2019 at the Leipzig University Medical Center, we characterized pathogen spectrum, clinical management and outcomes. Biliary malignancies (33%), cholelithiasis (23%) and ischemic biliary tract disease (16%) were most common causes of PLA. Comorbidities included malignancies (40%) and diabetes mellitus (35%). Abdominal ultrasound was the preferred initial imaging modality (58%). Enterobacterales (58%), enterococci (42%) and streptococci (18%) were identified as most frequent pathogens. 97% of patients were treated with antibiotics and 75% of patients underwent an invasive treatment procedure. The 30-day mortality was almost identical in patients with and without underlying malignancy (14.6% vs. 14.4%, p = 0.96), while the one-year outcome differed significantly (58.4% vs. 29.6%, p < 0.001). Positive blood cultures (OR 4.78, 95% CI 1.39 to 22.5, p = 0.023) and detection of Enterobacterales (OR 3.55, 95% CI 1.40 to 9.97, p = 0.010) were associated with increased 30-day-mortality. We conclude that ultrasound, extensive microbiologic diagnosis, adequate anti-infective therapy and early intervention are crucial for the management of PLA., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
25. [Painful ulcers in a young male refugee].
- Author
-
Jochims F, Lippmann N, and Simon JC
- Subjects
- Male, Humans, Pain diagnosis, Ulcer, Refugees
- Published
- 2024
- Full Text
- View/download PDF
26. [Cutaneous diphtheria].
- Author
-
Jochims F, Lippmann N, and Simon JC
- Subjects
- Humans, Diphtheria diagnosis, Corynebacterium diphtheriae
- Published
- 2024
- Full Text
- View/download PDF
27. Presence of hypervirulence-associated determinants in Klebsiella pneumoniae from hospitalised patients in Germany.
- Author
-
Wahl A, Fischer MA, Klaper K, Müller A, Borgmann S, Friesen J, Hunfeld KP, Ilmberger A, Kolbe-Busch S, Kresken M, Lippmann N, Lübbert C, Marschner M, Neumann B, Pfennigwerth N, Probst-Kepper M, Rödel J, Schulze MH, Zautner AE, Werner G, and Pfeifer Y
- Subjects
- Humans, Klebsiella pneumoniae, Virulence genetics, Virulence Factors genetics, Plasmids, Anti-Bacterial Agents pharmacology, Community-Acquired Infections microbiology, Klebsiella Infections microbiology
- Abstract
Background: Klebsiella (K.) pneumoniae is a ubiquitous Gram-negative bacterium and a common coloniser of animals and humans. Today, K. pneumoniae is one of the most persistent nosocomial pathogens worldwide and poses a severe threat/burden to public health by causing urinary tract infections, pneumonia and bloodstream infections. Infections mainly affect immunocompromised individuals and hospitalised patients. In recent years, a new type of K. pneumoniae has emerged associated with community-acquired infections such as pyogenic liver abscess in otherwise healthy individuals and is therefore termed hypervirulent K. pneumoniae (hvKp). The aim of this study was the characterisation of K. pneumoniae isolates with properties of hypervirulence from Germany., Methods: A set of 62 potentially hypervirulent K. pneumoniae isolates from human patients was compiled. Inclusion criteria were the presence of at least one determinant that has been previously associated with hypervirulence: (I) clinical manifestation, (II) a positive string test as a marker for hypermucoviscosity, and (III) presence of virulence associated genes rmpA and/or rmpA2 and/or magA. Phenotypic characterisation of the isolates included antimicrobial resistance testing by broth microdilution. Whole genome sequencing (WGS) was performed using Illumina® MiSeq/NextSeq to investigate the genetic repertoire such as multi-locus sequence types (ST), capsule types (K), further virulence associated genes and resistance genes of the collected isolates. For selected isolates long-read sequencing was applied and plasmid sequences with resistance and virulence determinants were compared., Results: WGS analyses confirmed presence of several signature genes for hvKp. Among them, the most prevalent were the siderophore loci iuc and ybt and the capsule regulator genes rmpA and rmpA2. The most dominant ST among the hvKp isolates were ST395 capsule type K2 and ST395 capsule type K5; both have been described previously and were confirmed by our data as multidrug-resistant (MDR) isolates. ST23 capsule type K1 was the second most abundant ST in this study; this ST has been described as commonly associated with hypervirulence. In general, resistance to beta-lactams caused by the production of extended-spectrum beta-lactamases (ESBL) and carbapenemases was observed frequently in our isolates, confirming the threatening rise of MDR-hvKp strains., Conclusions: Our study results show that K. pneumoniae strains that carry several determinants of hypervirulence are present for many years in Germany. The detection of carbapenemase genes and hypervirulence associated genes on the same plasmid is highly problematic and requires intensified screening and molecular surveillance. However, the non-uniform definition of hvKp complicates their detection. Testing for hypermucoviscosity alone is not specific enough to identify hvKp. Thus, we suggest that the classification of hvKp should be applied to isolates that not only fulfil phenotypical criteria (severe clinical manifestations, hypermucoviscosity) but also (I) the presence of at least two virulence loci e.g. iuc and ybt, and (II) the presence of rmpA and/or rmpA2., (Copyright © 2024 The Authors. Published by Elsevier GmbH.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
28. Rectal colonization is predictive for surgical site infections with multidrug-resistant bacteria in abdominal surgery.
- Author
-
Mehdorn M, Kolbe-Busch S, Lippmann N, Moulla Y, Scheuermann U, Jansen-Winkeln B, Chaberny IF, Gockel I, and Kassahun WT
- Subjects
- Humans, Drug Resistance, Multiple, Bacterial, Rectum surgery, Risk Factors, Anti-Bacterial Agents, Surgical Wound Infection epidemiology, Vancomycin-Resistant Enterococci
- Abstract
Purpose: Superficial surgical site infections (SSI) are a common complication after abdominal surgery. Additionally, multidrug-resistant organisms (MDRO) have shown an increasing spread in recent years with a growing importance for health care. As there is varying evidence on the importance of MDRO in different surgical fields and countries as causative agents of SSI, we report our findings of MDRO-caused SSI., Methods: We assembled an institutional wound register spanning the years 2015-2018 including all patients with abdominal surgery and SSI only, including demographics, procedure-related data, microbiological data from screenings, and body fluid samples. The cohort was examined for the frequency of different MDRO in screenings, body fluids, and wound swabs and assessed for risk factors for MDRO-positive SSI., Results: A total of 138 out of 494 patients in the register were positive for MDRO, and of those, 61 had an MDRO isolated from their wound, mainly multidrug-resistant Enterobacterales (58.1%) followed by vancomycin-resistant Enterococcus spp. (19.7%). As 73.2% of all MDRO-carrying patients had positive rectal swabs, rectal colonization could be identified as the main risk factor for an SSI caused by a MDRO with an odds ratio (OR) of 4.407 (95% CI 1.782-10.896, p = 0.001). Secondly, a postoperative ICU stay was also associated with an MDRO-positive SSI (OR 3.73; 95% CI 1.397-9.982; p = 0.009)., Conclusion: The rectal colonization status with MDRO should be taken into account in abdominal surgery regarding SSI prevention strategies. Trial registration Retrospectively registered in the German register for clinical trials (DRKS) 19th December 2019, registration number DRKS00019058., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
29. Extended-spectrum beta-lactamases found in Escherichia coli isolates obtained from blood cultures and corresponding stool specimen.
- Author
-
Doerr N, Dietze N, Lippmann N, and Rodloff AC
- Subjects
- Humans, Blood Culture, beta-Lactamases genetics, Microbial Sensitivity Tests, Ciprofloxacin pharmacology, Anti-Bacterial Agents pharmacology, Escherichia coli, Escherichia coli Infections drug therapy, Escherichia coli Infections epidemiology, Escherichia coli Infections microbiology
- Abstract
With extended-spectrum β-lactamases (ESBLs) and CTX-M enzymes being on the rise, antimicrobial treatment of enterobacterial infections is becoming more and more challenging. Our study aimed at a molecular characterization of phenotypically ESBL-positive E. coli strains obtained from blood cultures of patients of the University Hospital of Leipzig (UKL), Germany. The presence of CMY-2, CTX-M-14 and CTX-M-15 was investigated using Streck ARM-D Kit (Streck, USA). Real-time amplifications were performed by QIAGEN Rotor-Gene Q MDx Thermocycler (QIAGEN, Thermo Fisher Scientific, USA). Antibiograms as well as epidemiological data were evaluated. Among 117 cases, 74.4% of the isolates showed a resistance to ciprofloxacin, piperacillin and ceftazidime or cefotaxime while being susceptible to imipenem/meropenem. The proportion of ciprofloxacin resistance was significantly higher than the proportion of ciprofloxacin susceptibility. At least one of the investigated genes was detected in 93.1% of the blood culture E. coli isolates: CTX-M-15 (66.7%), CTX-M-14 (25.6%) or the plasmid-mediated ampC gene CMY-2 (3.4%). 2.6% were tested positive for two resistance genes. 94 of the corresponding stool specimens tested positive for ESBL producing E. coli (94/112, 83.9%). 79 (79/94, 84%) E. coli strains found in the stool samples matched with the respective patient's blood culture isolate phenotypically (MALDI-TOF, antibiogram). The distribution of resistance genes was in accordance with recent studies in Germany as well as worldwide. This study provides indications of an endogenous focus of infection and emphasize the importance of screening programs for high-risk patients., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
30. The Value of Perinatal Factors, Blood Biomarkers and Microbiological Colonization Screening in Predicting Neonatal Sepsis.
- Author
-
Cao I, Lippmann N, and Thome UH
- Abstract
Background: Neonatal sepsis is one of the most important causes of elevated morbidity and mortality rates in neonatal intensive care units worldwide. While the clinical manifestations of neonatal sepsis tend to be nonspecific, its rapid development and life-threatening potential call for reliable markers for early detection. Methods: We conducted a retrospective single-center study including all neonates suspected of having developed neonatal sepsis from 2013 to 2016. Perinatal and clinical characteristics as well as microbiological and laboratory findings were evaluated. Neonatal sepsis was defined as either culture-proven sepsis (positive blood culture) or clinical sepsis (at least one symptom and elevated C-reactive protein (CRP) concentrations within 72 h with negative blood culture). We further differentiated between early-onset (EOS) and late-onset (LOS) sepsis. Results: Microbiological colonization screening by throat and rectal swabs frequently did not detect the organism that subsequently caused the sepsis. Depending on the age of the newborn with sepsis (EOS or LOS), associations between different anamnestic and clinical factors (prenatal or postnatal ones) were found. In particular, the central−peripheral temperature difference showed a strong association with LOS. Laboratory results useful for the early detection of neonatal sepsis included interleukin-6 (IL-6) and CRP concentrations. Conclusions: Elevated IL-6 >100 ng/L was a strong marker for neonatal sepsis. When choosing the antibiotics for treatment, data from microbiological colonization screening should be considered but not solely relied on. Some indicators of infection also depended on postnatal age.
- Published
- 2022
- Full Text
- View/download PDF
31. Comparison of the certified Copan eSwab system with commercially available cotton swabs for the detection of multidrug-resistant bacteria in rectal swabs.
- Author
-
Lippmann N, Wendt S, Stîngu CS, Wiegand J, and Lübbert C
- Subjects
- Escherichia coli, Humans, Klebsiella pneumoniae, Pandemics, Prospective Studies, SARS-CoV-2, Vancomycin, COVID-19 diagnosis, Vancomycin-Resistant Enterococci
- Abstract
Background: Rectal swabs are well-implemented screening tools for multidrug-resistant bacteria (MDRB). Since certified swabs such as the Copan eSwab system experienced a delivery bottleneck during the COVID-19 pandemic, commercially available alternatives such as commonly used double-tipped cotton swabs had to be investigated, especially considering their similarity to professional cotton swabs for microbiological purposes., Methods: Diagnostic properties of commercial cotton swabs (comparable to Q-tips) and Copan eSwabs were qualitatively compared in a prospective single-center study using microbiological standard cultures and PCR methods for the detection of multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci (VRE)., Results: A total of 196 swab pairs were collected from 164 participants. MDRB were detected in 36 of 164 cases (22%). There were neither false-negative nor false-positive results using commercial cotton swabs. In 8 of 196 samples (4.1%) MDRB species were detected only by using cotton swabs, including vancomycin-resistant Enterococcus faecium, OXA-48 producing Escherichia coli, ESBL-producing Klebsiella pneumoniae and ESBL-producing Escherichia coli., Discussion: Commercial cotton swabs turned out to be a reliable alternative to Copan eSwabs. For practical use as a screening tool, relevant storage- and manufacturer-related contamination must be ruled out beforehand., Conclusions: Commonly available double-tipped cotton swabs can be used for rectal MDRB screening in the event of supply shortages of certified swabs. Further studies should clarify their suitability as a sampling system for nasopharyngeal MRSA carriage or even for the molecular biological detection of SARS-CoV-2., (Copyright © 2022 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
32. Pathogens and Shift of Resistance in Early Infections after Operative Fracture Fixation.
- Author
-
Oberhuber-Kurth LM, Angeli R, Lippmann N, Notov D, Osterhoff G, Frank K, Langer S, and Kohler L
- Subjects
- Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Antibiotic Prophylaxis, Drug Resistance, Bacterial, Fracture Fixation, Humans, Middle Aged, Retrospective Studies, Staphylococcus aureus, Staphylococcus epidermidis, Surgical Wound Infection prevention & control, Gram-Negative Bacteria, Staphylococcal Infections microbiology
- Abstract
Background: Surgical site infections (SSIs) remain a challenge for the healthcare system. During the last 30 years, the literature has shown an increase of gram-negative bacterial strains in multiple infectious sites and that cephalosporins have replaced penicillin as the gold standard in peri-operative antibiotic prophylaxis. This study aims to examine the recent bacterial spectrum in orthopedic early SSIs and to compare it with a historical cohort. Patients and Methods: Patients in a level 1 trauma center with an SSI within six weeks after open fixation of a fracture were analyzed in two adjacent periods from 2007 to 2012 (data pool 1; DP1) and 2013 to 2017 (data pool 2; DP2), retrospectively. The detected microbiologic pathogens and the associated resistograms from both time periods were compared. Results: Six hundred eighty-one smear tests and respective pathogens from the wounds of 463 patients (mean age, 62.6 ± 20 years) with SSIs were analyzed. The following pathogens were found most frequent: Staphylococcus epidermidis (DP1, 20.6%; DP2, 26.3%), Staphylococcus aureus (DP1, 27.1%; DP2, 16.5%), Enterococcus faecalis (DP1, 13.7%; DP2, 11.1%), Bacillus sp . (DP1, 3.0%; DP2, 5.3%), Escherichia coli (DP1, 5.1%; DP2, 4.1%), Pseudomonas aeruginosa (DP1, 3.7%; DP2, 2.5%). In DP2, there were lower primary early infection rates with Staphylococcus aureus than in DP1 (p = 0.002). In DP2, Staphylococcus epidermidis showed an oxacillin resistance in 90.6% and an increased resistance (79.8%; p = 0.069) to several classes of antibiotic agents compared to DP1. Conclusions: No bacterial shift toward gram-negative species was observed in this investigation. However, Staphylococcus epidermidis showed an increased antibiotic resistance in the more recent patient cohort. The incidence of SSIs with Staphylococcus aureus decreased substantially.
- Published
- 2022
- Full Text
- View/download PDF
33. Diagnosis at a Glance: Tapeworm Infestation.
- Author
-
Wendt S, Lippmann N, and Lübbert C
- Subjects
- Animals, Humans, Cestode Infections diagnosis, Cestoda
- Published
- 2022
- Full Text
- View/download PDF
34. Recurrent bacteremia with a hypermucoviscous Escherichia coli isolated from a patient with perihilar cholangiocarcinoma: insights from a comprehensive genome-based analysis.
- Author
-
Neumann B, Lippmann N, Wendt S, Karlas T, Lübbert C, Werner G, Pfeifer Y, and Schuster CF
- Subjects
- Escherichia coli genetics, Humans, Klebsiella pneumoniae, Plasmids, Virulence Factors genetics, Bacteremia, Bile Duct Neoplasms genetics, Escherichia coli Infections, Klatskin Tumor, Klebsiella Infections
- Abstract
Background: Escherichia coli (E. coli) is a common human pathogen, responsible for a broad spectrum of infections. Sites of infection can vary, but the hepato-biliary system is of particular concern due to the infection-associated formation of gallstones and the spread of pathogens from the bile ducts into the bloodstream., Case Presentation: The presented case is striking, as the detected isolate showed a positive string test. This hypermucoviscous phenotype is atypical for E. coli and a particular feature of hypervirulent Klebsiella pneumoniae (K. pneumoniae) variants., Objectives: To provide new insights into the genomic background of an E. coli strain with an unusual hypermucoviscous phenotype using hybrid short- and long-read sequencing approaches., Results: Complete hybrid assemblies of the E. coli genome and plasmids were done and used for genome based typing. Isolate 537-20 was assigned to the multilocus sequence type ST88 and serotype O8:H4. The strain showed a close relationship to avian pathogenic strains. Analysis of the chromosome and plasmids revealed the presence of several virulence factors, such as the Conserved Virulence Plasmidic (CVP) region on plasmid 537-20_1, including several iron acquisition genes (sitABCD, iroABCDEN, iucABCD, hbd) and the iutA gene encoding the receptor of the siderophore aerobactin. The hypermucoviscous phenotype could be caused by encapsulation of putative K. pneumoniae origin., Conclusions: Hybrid sequencing enabled detailed genomic characterization of the hypermucoviscous E. coli strain, revealing virulence factors that have their putative origin in K. pneumoniae., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
35. Evaluation of a Luminometric Cell Counting System in Context of Antimicrobial Photodynamic Inactivation.
- Author
-
Lehnig M, Glass S, Lippmann N, Ziganshyna S, Eulenburg V, and Werdehausen R
- Abstract
Antimicrobial resistance belongs to the most demanding medical challenges, and antimicrobial photodynamic inactivation (aPDI) is considered a promising alternative to classical antibiotics. However, the pharmacologic characterization of novel compounds suitable for aPDI is a tedious and time-consuming task that usually requires preparation of bacterial cultures and counting of bacterial colonies. In this study, we established and utilized a luminescence-based microbial cell viability assay to analyze the aPDI effects of two porphyrin-based photosensitizers (TMPyP and THPTS) on several bacterial strains with antimicrobial resistance. We demonstrate that after adaptation of the protocol and initial calibration to every specific bacterial strain and photosensitizer, the luminometric method can be used to reliably quantify aPDI effects in most of the analyzed bacterial strains. The interference of photosensitizers with the luminometric readout and the bioluminescence of some bacterial strains were identified as possible confounders. Using this method, we could confirm the susceptibility of several bacterial strains to photodynamic treatment, including extensively drug-resistant pathogens (XDR). In contrast to the conventional culture-based determination of bacterial density, the luminometric assay allowed for a much more time-effective analysis of various treatment conditions. We recommend this luminometric method for high-throughput tasks requiring measurements of bacterial viability in the context of photodynamic treatment approaches.
- Published
- 2022
- Full Text
- View/download PDF
36. The Meta -Substituted Isomer of TMPyP Enables More Effective Photodynamic Bacterial Inactivation than Para -TMPyP In Vitro.
- Author
-
Schulz S, Ziganshyna S, Lippmann N, Glass S, Eulenburg V, Habermann N, Schwarz UT, Voigt A, Heilmann C, Rüffer T, and Werdehausen R
- Abstract
Porphyrinoid-based photodynamic inactivation (PDI) provides a promising approach to treating multidrug-resistant infections. However, available agents for PDI still have optimization potential with regard to effectiveness, toxicology, chemical stability, and solubility. The currently available photosensitizer TMPyP is provided with a para substitution pattern (para-TMPyP) of the pyridinium groups and has been demonstrated to be effective for PDI of multidrug-resistant bacteria. To further improve its properties, we synthetized a structural variant of TMPyP with an isomeric substitution pattern in a meta configuration (meta-TMPyP), confirmed the correct structure by crystallographic analysis and performed a characterization with NMR-, UV/Vis-, and IR spectroscopy, photostability, and singlet oxygen generation assay. Meta-TMPyP had a hypochromic shift in absorbance (4 nm) with a 55% higher extinction coefficient and slightly improved photostability (+6.9%) compared to para-TMPyP. Despite these superior molecular properties, singlet oxygen generation was increased by only 5.4%. In contrast, PDI, based on meta-TMPyP, reduced the density of extended spectrum β-lactamase-producing and fluoroquinolone-resistant Escherichia coli by several orders of magnitude, whereby a sterilizing effect was observed after 48 min of illumination, while para-TMPyP was less effective (p < 0.01). These findings demonstrate that structural modification with meta substitution increases antibacterial properties of TMPyP in PDI.
- Published
- 2022
- Full Text
- View/download PDF
37. Surgical Revision Promotes Presence of Enterococcus spp. in Abdominal Superficial Surgical Site Infections.
- Author
-
Mehdorn M, Kassahun WT, Lippmann N, Scheuermann U, Groos L, Buchloh D, Jansen-Winkeln B, and Gockel I
- Subjects
- Anti-Bacterial Agents therapeutic use, Humans, Reoperation adverse effects, Risk Factors, Enterococcus, Surgical Wound Infection etiology
- Abstract
Background: Superficial surgical site infections (SSSIs) are a major reason for morbidity after abdominal surgery. Microbiologic isolates of SSSIs vary widely geographically. Therefore, knowledge about the specific bacterial profile is of paramount importance to prevent SSSI., Methods: We performed a subgroup analysis of the microbiological isolates from patients with SSSI after abdominal surgery that were included in our institutional wound register. We aimed at identifying predominant strains as well as risk factors that would predispose for SSSI with certain bacteria., Results: A total of 494 patients were eligible for analysis. Of those 313 had received wound swaps, with 268 patients yielding a bacterial isolate. Enterobacterales (31.7%) and Enterococcus spp. (29.5%) were found as main bacteria in SSSI, with 62.3% of the wounds being polymicrobial. As risk factors for changes in bacterial isolates, we identified operative revision (OR 3.032; 95%CI 1.734-5.303) in multivariate analysis. Enterococcus spp. showed a significant increase in patients after revision surgery (p<0.001). Antibiotic therapy was neither influential on bacterial changes nor on the presence of Enterococcus spp. in SSSI., Conclusion: Our study accentuates the high frequency of Enterococcus spp. in SSSI after abdominal surgery, while identifying surgical revision as major risk factor. The results urge vigilance in the treatment of patients with surgical revisions to include Enterococcus spp. in the prevention and treatment strategies., (© 2021. The Society for Surgery of the Alimentary Tract.)
- Published
- 2022
- Full Text
- View/download PDF
38. Context-aware genomic surveillance reveals hidden transmission of a carbapenemase-producing Klebsiella pneumoniae .
- Author
-
Viehweger A, Blumenscheit C, Lippmann N, Wyres KL, Brandt C, Hans JB, Hölzer M, Irber L, Gatermann S, Lübbert C, Pletz MW, Holt KE, and König B
- Subjects
- Bacterial Proteins chemistry, Bacterial Proteins genetics, Colistin pharmacology, Cross Infection epidemiology, Disease Outbreaks, Epidemiological Monitoring, Germany epidemiology, Humans, Klebsiella Infections microbiology, Klebsiella pneumoniae drug effects, Klebsiella pneumoniae genetics, Klebsiella pneumoniae isolation & purification, Membrane Transport Proteins chemistry, Models, Molecular, Phylogeny, Protein Conformation, Cross Infection microbiology, Drug Resistance, Bacterial, Klebsiella Infections epidemiology, Klebsiella pneumoniae classification, Membrane Transport Proteins genetics
- Abstract
Genomic surveillance can inform effective public health responses to pathogen outbreaks. However, integration of non-local data is rarely done. We investigate two large hospital outbreaks of a carbapenemase-carrying Klebsiella pneumoniae strain in Germany and show the value of contextual data. By screening about 10 000 genomes, over 400 000 metagenomes and two culture collections using in silico and in vitro methods, we identify a total of 415 closely related genomes reported in 28 studies. We identify the relationship between the two outbreaks through time-dated phylogeny, including their respective origin. One of the outbreaks presents extensive hidden transmission, with descendant isolates only identified in other studies. We then leverage the genome collection from this meta-analysis to identify genes under positive selection. We thereby identify an inner membrane transporter ( ynjC ) with a putative role in colistin resistance. Contextual data from other sources can thus enhance local genomic surveillance at multiple levels and should be integrated by default when available.
- Published
- 2021
- Full Text
- View/download PDF
39. Changes in antibiotic consumption, AMR and Clostridioides difficile infections in a large tertiary-care center following the implementation of institution-specific guidelines for antimicrobial therapy: A nine-year interrupted time series study.
- Author
-
Schönherr SG, Ranft D, Lippmann N, and Lübbert C
- Subjects
- Anti-Bacterial Agents pharmacology, Clostridioides difficile drug effects, Enterobacteriaceae drug effects, Germany, Humans, Interrupted Time Series Analysis, Linear Models, Practice Guidelines as Topic, Pseudomonas aeruginosa drug effects, Staphylococcus drug effects, Tertiary Care Centers, Antimicrobial Stewardship organization & administration, Clostridioides difficile growth & development, Clostridium Infections drug therapy, Drug Resistance, Bacterial
- Abstract
Background: Institution-specific guidelines (ISGs) within the framework of antimicrobial stewardship programs offer locally tailored decision support taking into account local pathogen and resistance epidemiology as well as national and international guidelines., Objectives: To assess the impact of ISGs for antimicrobial therapy on antibiotic consumption and subsequent changes in resistance rates and Clostridioides difficile infections (CDIs)., Methods: The study was conducted at the Leipzig University Hospital, a 1,451-bed tertiary-care medical center, and covered the years 2012 to 2020. Since 2014, ISGs were provided to optimize empirical therapies, appropriate diagnostics, and antimicrobial prophylaxis. We used interrupted time series analysis (ITSA) and simple linear regression to analyze changes in antimicrobial consumption, resistance and CDIs., Results: Over the study period, 1,672,200 defined daily doses (DDD) of antibiotics were dispensed, and 85,645 bacterial isolates as well as 2,576 positive C. difficile cultures were collected. Total antimicrobial consumption decreased by 14% from 2012 to 2020, without clear impact of the deployment of ISGs. However, implementation of ISGs was associated with significant decreases in the use of substances that were rarely recommended (e.g., fluoroquinolones). Over the whole study period, we observed declining resistance rates to most antibiotic classes of up to 25% in Enterobacterales, staphylococci, and Pseudomonas aeruginosa. Switching from ceftriaxone to cefotaxime was associated with reduced resistance to third-generation cephalosporins. The number of CDI cases fell by 65%, from 501 in 2012 to 174 in 2020., Conclusions: Well-implemented ISGs can have a significant, immediate, and lasting impact on the prescription behavior. ISGs might thereby contribute to reduce resistance rates and CDI incidences in the hospital setting., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2021
- Full Text
- View/download PDF
40. Antibiotic Resistance Patterns of Bacterial Isolates from Neonatal Sepsis Patients at University Hospital of Leipzig, Germany.
- Author
-
Tessema B, Lippmann N, Knüpfer M, Sack U, and König B
- Abstract
Neonatal sepsis caused by resistant bacteria is a worldwide concern due to the associated high mortality and increased hospitals costs. Bacterial pathogens causing neonatal sepsis and their antibiotic resistance patterns vary among hospital settings and at different points in time. This study aimed to determine the antibiotic resistance patterns of pathogens causing neonatal sepsis and to assess trends in antibiotic resistance. The study was conducted among neonates with culture proven sepsis at the University Hospital of Leipzig between November 2012 and September 2020. Blood culture was performed by BacT/ALERT 3D system. Antimicrobial susceptibility testing was done with broth microdilution method based on ISO 20776-1 guideline. Data were analyzed by SPSS version 20 software. From 134 isolates, 99 (74%) were gram positive bacteria. The most common gram positive and gram negative bacteria were S. epidermidis , 51 (38%) and E. coli , 23 (17%), respectively. S. epidermidis showed the highest resistance to penicillin G and roxithromycin (90% each) followed by cefotaxime, cefuroxime, imipenem, oxacillin, and piperacillin-tazobactam (88% each), ampicillin-sulbactam (87%), meropenem (86%), and gentamicin (59%). Moreover, S. epidermidis showed raising levels of resistance to amikacin, gentamicin, ciprofloxacin, levofloxacin, moxifloxacin, and cotrimoxazol. Gram positive bacteria showed less or no resistance to daptomycin, linezolid, teicoplanin, and vancomycin. E. coli showed the highest resistance to ampicillin (74%) followed by ampicillin-sulbactam (52%) and piperacillin (48%). Furthermore, increasing levels in resistance to ampicillin, ampicillin-sulbactam, piperacillin, and cefuroxime were observed over the years. Encouragingly, E. coli showed significantly declining trends of resistance to ciprofloxacin and levofloxacin, and no resistance to amikacin, colistin, fosfomycin, gentamicin, imipenem, piperacillin-tazobactam, and tobramycin. In conclusion, this study demonstrates that gram positive bacteria were the leading causes of neonatal sepsis. Bacterial isolates were highly resistant to first and second-line empiric antibiotics used in this hospital. The high levels of antibiotic resistance patterns highlight the need for modifying empiric treatment regimens considering the most effective antibiotics. Periodic surveillance in hospital settings to monitor changes in pathogens, and antibiotic resistance patterns is crucial in order to implement optimal prevention and treatment strategies.
- Published
- 2021
- Full Text
- View/download PDF
41. Photosensitizer-loaded hydrogels for photodynamic inactivation of multirestistant bacteria in wounds.
- Author
-
Glass S, Kühnert M, Lippmann N, Zimmer J, Werdehausen R, Abel B, Eulenburg V, and Schulze A
- Abstract
Photodynamic treatment is a promising tool for the therapy of multidrug-resistant bacteria. In this study, we highlight photosensitizer-loaded hydrogels as an application system for infected wounds. The poly(ethylene glycol) diacrylate-based and electron beam-polymerized hydrogels were mechanically stable and transparent. They were loaded with two photoactive, porphyrin-based drugs - tetrakis(1 methylpyridinium-4-yl)porphyrin p -toluenesulfonate (TMPyP) and tetrahydroporphyrin - p toluenesulfonate (THPTS). The hydrogels released a sufficient amount of the photosensitizers (up to 300 μmol l
-1 ), relevant for efficiency. The antimicrobial effectivity of loaded hydrogels was investigated in a tissue-like system as well as in a liquid system against a multiresistant Escherichia coli . In both systems, light induced eradication was possible. In contrast, hydrogels alone showed only minor antimicrobial activity. Furthermore, the loaded hydrogels were successfully tested against seven multidrug-resistant bacterial strains, namely Enterococcus faecium , Staphylococcus aureus , Klebsiella pneumonia , Acinetobacter baumannii , Pseudomonas aeruginosa , Escherichia coli and Achromobacter xylosoxidans . The eradication of these pathogens, except A. xylosoxidans , was successfully demonstrated. In general, TMPyP-loaded hydrogels were more effective than THPTS-loaded ones. Nevertheless, both photosensitizers displayed effectivity against all investigated bacteria strains. Taken together, our data demonstrate that photosensitizer-loaded hydrogels are a promising new tool to improve the treatment of wounds infected with problematic bacterial pathogens., Competing Interests: There are no conflicts to declare., (This journal is © The Royal Society of Chemistry.)- Published
- 2021
- Full Text
- View/download PDF
42. Hypervirulent Klebsiella pneumoniae of Lineage ST66-K2 Caused Tonsillopharyngitis in a German Patient.
- Author
-
Klaper K, Wendt S, Lübbert C, Lippmann N, Pfeifer Y, and Werner G
- Abstract
Hypervirulent Klebsiella pneumoniae (hvKp) is a novel pathotype that has been rarely described in Europe. This study characterizes a hvKp isolate that caused a community-acquired infection. The hypermucoviscous Klebsiella pneumoniae ( K. pneumoniae ) strain 18-0005 was obtained from a German patient with tonsillopharyngitis in 2017. Antibiotic susceptibility testing was performed and the genome was sequenced by Illumina and Nanopore technology. Whole genome data were analyzed by conducting core genome multilocus sequence typing (cgMLST) and single nucleotide polymorphism (SNP) analysis. Virulence genes were predicted by applying Kleborate. Phenotypic and whole genome analyses revealed a high similarity of the study isolate 18-0005 to the recently reported antibiotic-susceptible hvKp isolate SB5881 from France and the "ancestral" strain Kp52.145; both were assigned to the ST66-K2 lineage. Comparative genomic analysis of the three plasmids showed that the 18-0005 plasmid II differs from SB5881 plasmid II by an additional 3 kb integrated fragment of plasmid I. Our findings demonstrate the genetic flexibility of hvKp and the occurrence of a strain of the clonal group CG66-K2 in Germany. Hence, it emphasizes the need to improve clinical awareness and infection monitoring of hvKp.
- Published
- 2021
- Full Text
- View/download PDF
43. The Diagnostic Performance of Interleukin-6 and C-Reactive Protein for Early Identification of Neonatal Sepsis.
- Author
-
Tessema B, Lippmann N, Willenberg A, Knüpfer M, Sack U, and König B
- Abstract
Interleukin-6 (IL-6) and C-reactive protein (CRP) are being used for diagnosis of sepsis. However, studies have reported varying cut-off levels and diagnostic performance. This study aims to investigate the optimal cut-off levels and performance of IL-6 and CRP for the diagnosis of neonatal sepsis. The study was conducted at the University Hospital of Leipzig, Germany from November 2012 to June 2020. A total of 899 neonates: 104 culture proven sepsis, 160 clinical sepsis, and 625 controls were included. Blood culture was performed using BacT/ALERT 3D system. IL-6 and CRP were analyzed by electrochemiluminescent immunoassay and immunoturbidimetric assay, respectively. Data were analyzed using SPSS 20 statistical software. Among neonates with proven sepsis, the optimal cut-off value of IL-6 was 313.5 pg/mL. The optimal cut-off values for CRP in 5 days serial measurements (CRP1, CRP2, CRP3, CRP4, and CRP5) were 2.15 mg/L, 8.01 mg/L, 6.80 mg/L, 5.25 mg/L, and 3.72 mg/L, respectively. IL-6 showed 73.1% sensitivity, 80.2% specificity, 37.6% PPV, and 94.8% NPV. The highest performance of CRP was observed in the second day with 89.4% sensitivity, 97.3% specificity, 94.5% PPV, and 98.3% NPV. The combination of IL-6 and CRP showed increase in sensitivity with decrease in specificity. In conclusion, this study defines the optimal cut-off values for IL-6 and CRP. The combination of IL-6 and CRP demonstrated increased sensitivity. The CRP 2 at cut-off 8.01 mg/L showed the highest diagnostic performance for identification of culture negative clinical sepsis cases. We recommend the combination of IL-6 (≥313.5 pg/mL) and CRP1 (≥2.15 mg/L) or IL-6 (≥313.5 pg/mL) and CRP2 (≥8.01 mg/L) for early and accurate diagnosis of neonatal sepsis. The recommendation is based on increased sensitivity, that is, to minimize the risk of any missing cases of sepsis. The CRP2 alone at cut-off 8.01 mg/L might be used to identify clinical sepsis cases among culture negative sepsis suspected neonates in hospital settings.
- Published
- 2020
- Full Text
- View/download PDF
44. Development of the Bacterial Spectrum and Antimicrobial Resistance in Surgical Site Infections of Trauma Patients.
- Author
-
Eisner R, Lippmann N, Josten C, Rodloff AC, and Behrendt D
- Subjects
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Anti-Bacterial Agents administration & dosage, Antibiotic Prophylaxis methods, Drug Resistance, Multiple, Bacterial, Female, Humans, Male, Middle Aged, Operative Time, Retrospective Studies, Risk Factors, Sex Factors, Young Adult, Anti-Bacterial Agents pharmacology, Arthroscopy adverse effects, Drug Resistance, Bacterial, Surgical Wound Infection microbiology, Wounds and Injuries surgery
- Abstract
Background: While ubiquitously multi-resistant bacteria are on the rise, peri-operative antimicrobial prophylaxis in trauma and near-to-bone surgical procedures has only been changed slightly during the last 25 years. Recent clinical studies concerning the bacterial spectrum and efficacy of antimicrobial treatment in infected trauma surgical patients are rare. The aim of the study was analysis of the contemporary bacterial spectrum and its antimicrobial resistance including the assessment of the appropriateness of peri-operative antimicrobial prophylaxis with cefuroxime. Methods: Patients of a level-I academic trauma center who underwent open or arthroscopic surgery because of a recent trauma necessitating the use of bone-near metal implants were included in the study. All patients in whom a surgical site infection (SSI) had developed during six weeks post-operatively necessitating surgical debridement and had positive microbiologic culture results from an intra-operative surgical site swab were analyzed, retrospectively. In particular, age, gender, date and duration of surgical interventions, and patient's related risk factors were collected, and infecting agents and their minimum inhibitory concentration values for 34 selected antimicrobial agents were evaluated. An SSI occurring later than 6 weeks post-operatively and patients with chronic and septic wounds were excluded. Statistical analysis was performed with SPSS
® (IBM, Armonk, NY). Results: There were 438 pathogens cultured in specimens from 303 enrolled patients (female = 140, male = 163). The most frequent pathogens were Staphylococcus aureus (27.1%), S. epidermidis (20.6%), Enterococcus faecalis (13.6%), Escherichia coli (5.1%), and Pseudomonas aeruginosa (3.7%) accounting for 303 isolates. Of those, 89 (29.4%) were multi-resistant. Of the S. epidermidis isolates, 79.8% (n = 71) were resistant against Oxacillin and thus against most beta-lactam antibiotic agents. Altogether, only 44.1% of the infecting organisms were susceptible to cefuroxime, the antimicrobial agent most often being used for prophylactic purposes. Conclusion: Standardized antimicrobial prophylaxis with cephalosporins has to be reconsidered critically. Multi-resistant species such as S. epidermidis are an increasing challenge in trauma operations.- Published
- 2020
- Full Text
- View/download PDF
45. Switching From Ceftriaxone to Cefotaxime Significantly Contributes to Reducing the Burden of Clostridioides difficile infections.
- Author
-
Wendt S, Ranft D, Rodloff AC, Lippmann N, and Lübbert C
- Abstract
We analyzed Clostridioides difficile infection (CDI) rates and various antimicrobials' application densities from 2013 to 2019 at Leipzig University Hospital, Germany, by using multivariate linear regression. Ceftriaxone application was the only independent predictor of CDI incidence. Thus, antibiotics' specific pharmacokinetic and pharmacodynamic properties such as biliary excretion of ceftriaxone in its active form should be considered when determining their potential to cause CDI., (© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
- Published
- 2020
- Full Text
- View/download PDF
46. Tetrahydroporphyrin-tetratosylate (THPTS)-based photodynamic inactivation of critical multidrug-resistant bacteria in vitro.
- Author
-
Ziganshyna S, Guttenberger A, Lippmann N, Schulz S, Bercker S, Kahnt A, Rüffer T, Voigt A, Gerlach K, and Werdehausen R
- Subjects
- Anti-Bacterial Agents pharmacology, Drug Resistance, Multiple, Bacterial, Humans, Lasers, Light, Microbial Sensitivity Tests, Microbial Viability, Photochemotherapy methods, Semiconductors, Bacteria drug effects, Bacteria radiation effects, Bacterial Infections drug therapy, Photosensitizing Agents pharmacology, Porphyrins pharmacology
- Abstract
Background: Photodynamic inactivation (PDI) is a promising approach to treat multidrug-resistant infections. However, effectiveness of PDI is limited, particularly in Gram-negative bacteria. The use of photosensitizer (PS) 3,3',3'',3'''-(7,8,17,18-tetrahydro-21H,23H-porphyrine-5,10,15,20-tetrayl)tetrakis[1-methyl-pyridinium]tetratosylate (THPTS) and laser light has led to very promising results. This study focuses on the effects of THPTS in various critical multidrug-resistant bacterial strains and explores the possibility of light-emitting diode (LED)-based activation as a clinically more feasible alternative to laser light., Methods: THPTS was further chemically characterized and in vitro testing of PDI of different multidrug-resistant bacterial strains was performed under various experimental conditions, including varying drug concentration, incubation time, light source (laser and LED) and light intensity, by determination of viable bacteria after treatment. The effect of hyaluronic acid as an adjuvant for medical applications was also evaluated., Results: Bacterial density of all investigated bacterial strains was reduced by several orders of magnitude, irrespective of multidrug-resistance or hyaluronic acid addition. The effect was less intense in Gram-negative strains (disinfection), and more pronounced in Gram-positive strains (sterilization), even at reduced THPTS concentrations or decreased light treatment intensity. Controls without THPTS or without light treatment did not indicate reduced bacterial density., Conclusions: PDI with THPTS and laser light was effective in all investigated bacterial strains. Gram-negative strains were less, but sufficiently, susceptible to PDI. Adding hyaluronic acid did not reduce the antibacterial treatment effect. LED-based PDI is equally effective when illumination duration is increased to compensate for reduced light intensity., (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
47. Relocating a pediatric hospital: Does antimicrobial resistance change?
- Author
-
Schönfeld A, Ascherl R, Petzold-Quinque S, Lippmann N, Rodloff AC, and Kiess W
- Subjects
- Child, Humans, Retrospective Studies, Anti-Bacterial Agents, Drug Resistance, Bacterial, Hospitals, Pediatric statistics & numerical data, Hospitals, University statistics & numerical data, Microbial Sensitivity Tests statistics & numerical data
- Abstract
Objective: Analyze the changes in antimicrobial drug resistance patterns due to hospital relocation. To this end, we conducted a retrospective analysis of microbiological results, especially minimum inhibitory concentrations (MIC) of all isolates from blood, urine and bronchial secretions, in our pediatric university hospital before and after moving to a new building., Results: While the number of tests done did not change, the fraction of those positive increased, more MICs were determined and certain microbes (A. baumannii, E. faecalis, Klebsiella spp. and P. mirabilis) were detected more frequently. Most changes in MICs occurred in E. faecium (increases in 8 antimicrobials, decreases only in linezolid and gentamicin). For imipenem and aminopenicillins the MICs commonly rose after relocation, the opposite is true for gentamicin and trimethoprim/sulfamethoxazole. The other factors that alter by moving a hospital such as changes in medical personnel or case severity cannot be corrected for, but using MICs we are able to provide insights into changes down to the individual antimicrobial drug and even small changes usually undetectable to the common categorical reporting of resistance.
- Published
- 2020
- Full Text
- View/download PDF
48. Hospital-wide ELectronic medical record evaluated computerised decision support system to improve outcomes of Patients with staphylococcal bloodstream infection (HELP): study protocol for a multicentre stepped-wedge cluster randomised trial.
- Author
-
Hagel S, Gantner J, Spreckelsen C, Fischer C, Ammon D, Saleh K, Phan-Vogtmann LA, Heidel A, Müller S, Helhorn A, Kruse H, Thomas E, Rißner F, Haferkamp S, Vorwerk J, Deffge S, Juzek-Küpper MF, Lippmann N, Lübbert C, Trawinski H, Wendt S, Wendt T, Dürschmid A, Konik M, Moritz S, Tiller D, Röhrig R, Schulte-Coerne J, Fortmann J, Jonas S, Witzke O, Rath PM, Pletz MW, and Scherag A
- Subjects
- Cluster Analysis, Germany, Hospitals, University, Humans, Anti-Bacterial Agents therapeutic use, Decision Support Systems, Clinical, Electronic Health Records statistics & numerical data, Research Design, Staphylococcal Infections drug therapy
- Abstract
Introduction: Staphylococci are the most commonly identified pathogens in bloodstream infections. Identification of Staphylococcus aureus in blood culture (SAB) requires a prompt and adequate clinical management. The detection of coagulase-negative staphylococci (CoNS), however, corresponds to contamination in about 75% of the cases. Nevertheless, antibiotic therapy is often initiated, which contributes to the risk of drug-related side effects. We developed a computerised clinical decision support system (HELP-CDSS) that assists physicians with an appropriate management of patients with Staphylococcus bacteraemia. The CDSS is evaluated using data of the Data Integration Cent ers (DIC) established at each clinic. DICs transform heterogeneous primary clinical data into an interoperable format, and the HELP-CDSS displays information according to current best evidence in bacteraemia treatment. The overall aim of the HELP-CDSS is a safe but more efficient allocation of infectious diseases specialists and an improved adherence to established guidelines in the treatment of SAB., Methods and Analysis: The study is conducted at five German university hospitals and is designed as a stepped-wedge cluster randomised trial. Over the duration of 18 months, 135 wards will change from a control period to the intervention period in a randomised stepwise sequence. The coprimary outcomes are hospital mortality for all patients to establish safety, the 90-day disease reoccurrence-free survival for patients with SAB and the cumulative vancomycin use for patients with CoNS bacteraemia. We will use a closed, hierarchical testing procedure and generalised linear mixed modelling to test for non-inferiority of the CDSS regarding hospital mortality and 90-day disease reoccurrence-free survival and for superiority of the HELP-CDSS regarding cumulative vancomycin use., Ethics and Dissemination: The study is approved by the ethics committee of Jena University Hospital and will start at each centre after local approval. Results will be published in a peer-reviewed journal and presented at scientific conferences., Trial Registration Number: DRKS00014320., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2020
- Full Text
- View/download PDF
49. How are travellers colonized with antimicrobial-resistant bacteria?
- Author
-
Wendt S, Böhm P, Daniel J, Lippmann N, and Lübbert C
- Subjects
- Humans, India, Carbapenem-Resistant Enterobacteriaceae drug effects, Drug Resistance, Bacterial, Enterobacteriaceae Infections transmission, Travel
- Published
- 2020
- Full Text
- View/download PDF
50. [Typhoid and paratyphoid fever].
- Author
-
Trawinski H, Wendt S, Lippmann N, Heinitz S, von Braun A, and Lübbert C
- Subjects
- Anti-Bacterial Agents therapeutic use, Cephalosporins therapeutic use, Fluoroquinolones therapeutic use, Humans, Microbial Sensitivity Tests, Paratyphoid Fever diagnosis, Paratyphoid Fever microbiology, Quinolones therapeutic use, Salmonella enterica, Salmonella paratyphi A isolation & purification, Salmonella typhi isolation & purification, Typhoid Fever diagnosis, Typhoid Fever microbiology, Anti-Bacterial Agents pharmacology, Paratyphoid Fever drug therapy, Paratyphoid Fever prevention & control, Salmonella paratyphi A drug effects, Salmonella typhi drug effects, Typhoid Fever drug therapy, Typhoid Fever prevention & control, Vaccines, Conjugate administration & dosage
- Abstract
Typhoid fever and paratyphoid fever are systemic infectious diseases of global significance caused by Salmonella enterica subspecies enterica Serovar Typhi (short name: Salmonella Typhi) or Serovar Paratyphi (short name: Salmonella Paratyphi). The course of these fecal-orally transmitted diseases is mainly characterized by a high fever. Left untreated, the course of typhoid fever can be severe and lethal. The infection is almost always acquired outside of Europe (mainly in India) and is notifiable in Germany, Austria and Switzerland. Paratyphoid is an attenuated disease of typhoid fever caused by Salmonella Paratyphi. Available vaccines only protect against Salmonella Typhi. Antibiotic resistance reflects the situation in endemic countries and shows a worrying increase of multi-drug resistant isolates. Currently, third-generation cephalosporins such as ceftriaxone are recommended as first-line therapy; if sensitive to quinolones, fluoroquinolones such as ciprofloxacin may continue to be administered. Crucial preventive measures for travelers to endemic regions include consistent water and food hygiene as well as vaccination, whereby only protection rates of 50-70 % are achieved by currently available vaccines. In the light of increasing multi-drug resistance, a more effective conjugate vaccine against Salmonella Typhi with cross-reactivity against Salmonella Paratyphi is needed more than ever., Competing Interests: Die Autoren geben an, dass kein Interessenkonflikt besteht., (© Georg Thieme Verlag KG Stuttgart · New York.)
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.